Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Recombinant kallikrein inhibitor

EU orphan designation number: EU/3/09/712   
Active ingredient: Recombinant kallikrein inhibitor
Indication: Treatment of Netherton syndrome
Sponsor: Dermadis S.A.S.
Technopole d’Archamps, Bâtiment Le Forum II, 74160 Archamps, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/02/2010 Orphan designation EMEA/OD/106/09 (2010)712 of 29/01/2010
13/01/2012 Transfer of orphan designation EMEA/OD/106/09/T/01 (2012)136 of 11/01/2012